VA Northern California Health Care System
18
0
0
15
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 18 trials
100.0%
+13.5% vs industry average
11%
2 trials in Phase 3/4
47%
7 of 15 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (18)
Beta Adrenergic Antagonist for the Healing of Chronic DFU
Role: collaborator
Prospective RCT Of Water Exchange (WE) vs. WE Plus Cap-Assisted Colonoscopy
Role: collaborator
Pilot Testing a New Computer-based Screening Tool to Detect Cognitive Impairment
Role: collaborator
Absorption and Safety of Topical Timolol to Treat Chronic Wounds
Role: lead
Brain Markers of Improvements in Cognitive Functioning
Role: collaborator
A Prospective Analysis on the Expansion Rates of Abdominal Aortic Aneurysms
Role: lead
VA MERIT: A Comparative Efficacy Study: Treatment of Non-Healing Diabetic
Role: collaborator
Underwater Resection of Non-pedunculated Colorectal Lesions
Role: lead
Remotely Deployed TBI Study
Role: lead
Phase 1 Study of HF-LED-RL in Fitzpatrick Skin Types I to III
Role: lead
Effects of Vaporized Marijuana on Neuropathic Pain
Role: collaborator
Coaching to Improve Care of Cancer Pain
Role: collaborator
Vaporized Cannabis and Spinal Cord Injury Pain
Role: collaborator
High Fluence Light Emitting Diode-Red Light (LED-RL) in Human Skin
Role: collaborator
Voluma Filler Agent For The Treatment of HIV-associated Facial Lipoatrophy
Role: collaborator
Combined Chromoendoscopy and Water Method for Screening Colonoscopy
Role: lead
Unsedated Colonoscopy for Colorectal Cancer Screening and Surveillance
Role: lead
Docosahexenoic Acid (DHA) Supplementation and Cardiovascular Disease in Men With High Triglycerides
Role: collaborator
All 18 trials loaded